Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Here, Peter Valk, PhD, from the Erasmus University Medical Center, Rotterdam, Netherlands, discusses whole transcriptome RNA sequencing in acute myeloid leukemia (AML), at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands. This study investigated prognostic mutations, markers and expression levels such as EVR1.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.